Monthly Extracts Newsletter 

Edition 7 – October 2020
Your Guide To Quality Control In CBD 3.0 
 November 3, 2020 – 8 min read 
 Author: Dave Neundorfer 

Over the past few months, we’ve shared our perspective on what the cannabinoid industry needs to graduate from a nascent, $1B industry into the mainstream, cross-category, $20B+ powerhouse that analysts have heralded since the passing of the 2018 farm bill. This shift is happening now, driven by research, innovation, and a flight to quality by forward-thinking brands and the CPG “buyers of tomorrow.” 

At OBX, most of our research and innovation has been focused on minor cannabinoid production and formulation and downstream technological advancements that make those ingredients and formulations more effective and palatable to the mainstream consumer. 

Minor Cannabinoid Production and Formulation: We’ve blogged about the therapeutic potential of CBN, CBDV, THCV, & CBC, which are already playing a critical role in delivering function-specific formulations that the market demands. Working with minor cannabinoids demands production, testing, and product development rigor and precision, an all-hands on deck pursuit between partners like LYGOS, our in-house ops and quality assurance teams, and our 3rd-party control laboratory. 

Technological Advancements: We’ve partnered with other high-integrity organizations like Prinova and Volunteer Botanicals to fuel our ingredient innovation pipeline for our current clients and the buyers of tomorrow. Prinova is our nano-emulsification partner that can convert any of our cannabinoids into water soluble powder or liquid, whereas Volunteer Botanical can convert cannabinoids into a standardized, flowable powder that can be used for precisely dosed dissolvable tabs or capsules. Both of these innovation partners help streamline the adoption of cannabinoids into the routines of mainstream consumers. 

Over the past few months, we’ve shared our perspective on what the cannabinoid industry needs to graduate from a nascent, $1B industry into the mainstream, cross-category, $20B+ powerhouse that analysts have heralded since the passing of the 2018 farm bill. This shift is happening now, driven by research, innovation, and a flight to quality by forward-thinking brands and the CPG “buyers of tomorrow.” 

At OBX, most of our research and innovation has been focused on minor cannabinoid production and formulation and downstream technological advancements that make those ingredients and formulations more effective and palatable to the mainstream consumer. 

Minor Cannabinoid Production and Formulation: We’ve blogged about the therapeutic potential of CBN, CBDV, THCV, & CBC, which are already playing a critical role in delivering function-specific formulations that the market demands. Working with minor cannabinoids demands production, testing, and product development rigor and precision, an all-hands on deck pursuit between partners like LYGOS, our in-house ops and quality assurance teams, and our 3rd-party control laboratory. 

Technological Advancements: We’ve partnered with other high-integrity organizations like Prinova and Volunteer Botanicals to fuel our ingredient innovation pipeline for our current clients and the buyers of tomorrow. Prinova is our nano-emulsification partner that can convert any of our cannabinoids into water soluble powder or liquid, whereas Volunteer Botanical can convert cannabinoids into a standardized, flowable powder that can be used for precisely dosed dissolvable tabs or capsules. Both of these innovation partners help streamline the adoption of cannabinoids into the routines of mainstream consumers. 

Educational Content 

The Potential of Cannabidivarin

What are the therapuetic potentials of CBDV?

In this blog, we dive in to all the most recent and relevant scientific research that looks into the positive effects of CBDV.

Cannabinoids and the Stress Market

The anxiety and stress treatment market is expected to be worth $18.3 billion by 2025. At the same time, the relaxation beverages market, the functional foods market, the aromatherapy, and the sleep market are also expected to grow independently.

In this blog we break down the current solutions to stress and anxiety and where cannabinoids can play a critical role in the future of this category.

Industry News Roundup
Cannabis Leaf

New York tries to restore order to CBD market, clears way for hemp-infused drinks

Read More
CBD Eczima Cream

Turning Point Brands Backs Cannabinoid Company Dosist With $15M

Read More
CBD Research

Circle K boosts CBD offerings in southeastern US

Read More

Featured Products Unboxing Videos

 

A look behind the curtain at some of the high-purity ingredient products that we know will take your formulations to the next level.

CBN Isolate
10N Distillate
CBDV Isolate
THCV Isolate

Sharing is caring!

Recent Posts

New Formulations, New Sensations

Formulation Strategies For Minor Cannabinoids (+ Products We Love)Author: Nicole Brown (OBX Chief Revenue Officer)Jan 4, 2021 - 8 min read"Hey hey, are you ready for ? (New formulations, new formulations) Right now Gonna take you over (New formulations, new...

read more
Our team is your team and we want to share our knowledge with you.

Our team is your team and we want to share our knowledge with you.

 

Join over 2000 of your industry peers following along.

 

 

Subscribe to receive the latest industry updates, news from OBX, and special offers.

You have Successfully Subscribed!